These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 29218397)
1. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas. Tulla KA; Maker AV Langenbecks Arch Surg; 2018 Mar; 403(2):151-194. PubMed ID: 29218397 [TBL] [Abstract][Full Text] [Related]
2. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant. Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889 [TBL] [Abstract][Full Text] [Related]
3. [Branch duct intraductal papillary mucinous neoplasm - contra resection]. Brunner M; Weber GF; Kersting S; Grützmann R Chirurg; 2017 Nov; 88(11):918-926. PubMed ID: 28871376 [TBL] [Abstract][Full Text] [Related]
4. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas. Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244 [TBL] [Abstract][Full Text] [Related]
5. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus. Tanaka M Digestion; 2014; 90(4):265-72. PubMed ID: 25591885 [TBL] [Abstract][Full Text] [Related]
6. Molecular Diagnostics in the Evaluation of Pancreatic Cysts. Theisen BK; Wald AI; Singhi AD Surg Pathol Clin; 2016 Sep; 9(3):441-56. PubMed ID: 27523971 [TBL] [Abstract][Full Text] [Related]
7. Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. Pea A; Yu J; Rezaee N; Luchini C; He J; Dal Molin M; Griffin JF; Fedor H; Fesharakizadeh S; Salvia R; Weiss MJ; Bassi C; Cameron JL; Zheng L; Scarpa A; Hruban RH; Lennon AM; Goggins M; Wolfgang CL; Wood LD Ann Surg; 2017 Jul; 266(1):133-141. PubMed ID: 27433916 [TBL] [Abstract][Full Text] [Related]
8. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms. Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome. Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555 [TBL] [Abstract][Full Text] [Related]
10. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. Mimura T; Masuda A; Matsumoto I; Shiomi H; Yoshida S; Sugimoto M; Sanuki T; Yoshida M; Fujita T; Kutsumi H; Ku Y; Azuma T J Clin Gastroenterol; 2010 Oct; 44(9):e224-9. PubMed ID: 20453661 [TBL] [Abstract][Full Text] [Related]
11. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers. Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266 [TBL] [Abstract][Full Text] [Related]
12. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis. Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076 [TBL] [Abstract][Full Text] [Related]
14. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas. Corcos O; Couvelard A; Dargère D; Sauvanet A; Hammel P; Paradis V; Lévy P; Ruszniewski P; Bedossa P Pancreas; 2012 Mar; 41(2):169-74. PubMed ID: 22076567 [TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms. Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069 [TBL] [Abstract][Full Text] [Related]
16. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines. Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172 [TBL] [Abstract][Full Text] [Related]
17. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108 [TBL] [Abstract][Full Text] [Related]
18. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Pelaez-Luna M; Chari ST; Smyrk TC; Takahashi N; Clain JE; Levy MJ; Pearson RK; Petersen BT; Topazian MD; Vege SS; Kendrick M; Farnell MB Am J Gastroenterol; 2007 Aug; 102(8):1759-64. PubMed ID: 17686073 [TBL] [Abstract][Full Text] [Related]